Adlyxin vs Rybelsus

Adlyxin is a once-daily injectable diabetes medication containing the active ingredient lixisenatide, made by Sanofi, while Rybelsus is a daily oral tablet containing semaglutide, made by Novo Nordisk. Both are FDA-approved to treat type 2 diabetes, but Adlyxin is given as an injection under the skin, whereas Rybelsus is taken by mouth as a pill.

AI summary of the sources below.